Spread the love“`html In a competitive job market, especially in the tech industry, having a standout resume is crucial. With hiring processes becoming more stringent, tech job seekers must leverage ...

With AI used to screen resumes, you'll need more than having the most matching keywords. Maribel Aber has tips from a hiring expert on landing an interview. US releases official agreement with Iran.

I wore the world's first HDR10 smart glasses TCL's new E Ink tablet beats the Remarkable and Kindle Anker's new charger is one of the most unique I've ever seen Best laptop cooling pads Best flip ...

Apple's recently announced iOS 27 update won't officially ship until the fall, but you can get a taste of the performance improvements and new Siri features the company showed off at WWDC 2026 by ...

Nasha is a Managing Editor for CNET, overseeing our sleep and wellness verticals. She is a nutrition, mental health, fitness and sleep science enthusiast. Her passion for mindful and holistic ...

Apple announced cross-developer bundles, group subscriptions, volume purchasing, and AI-driven discovery tools for the App Store at WWDC 2026. Apple announced a sweeping set of changes to the App ...

Tim Cook holds his last Apple event as CEO today. Don't expect any new hardware, but the rumored software updates may surprise you. Dashia is the consumer insights editor for CNET. She specializes in ...

Apple has announced iOS 27, with key new features including "Siri AI" and a Siri app, a slider to adjust the appearance of Liquid Glass, expanded child safety features, faster performance, "tons of ...

Meta Platforms META-0.29%decrease; down pointing triangle has delayed plans to release its newest artificial intelligence model to developers multiple times and as of Tuesday didn’t have a planned ...

LimmaTech's lead program targets S. aureus, a major cause of surgical-site infections Vaccine Company acquisition includes experimental vaccine for Epstein-Barr virus Curevo is developing shingles ...

Eli Lilly has splashed up to $3.8 billion on an infectious disease pipeline, acquiring Curevo, LimmaTech Biologics and Vaccine Company to extend its buying spree into viral and bacterial pathogen R&D.